- Top 1% of respondersArk Biotech is in the top 1% of companies in terms of response time to applications
- Responds within a dayBased on past data, Ark Biotech usually responds to incoming applications within a day
- B2B
- +3
Frontend Software Engineer
- $100k – $140k
- 2 years of exp
- Full Time
Not Available
In office - WFH flexibility
About the job
Ark is building is a novel simulation platform for biomanufacturing, accelerating the development and production of new drugs for leading biotech and pharma companies. Our team is made up of world-renowned experts in bioprocessing, biomanufacturing, simulation and automation, all working together to create the first platform capable of accurately modeling and optimizing the production of modern biological drugs.
Our simulation engine, or “virtual bioreactor,” frees Ark customers from the limits of the wet-lab, allowing them to run unlimited experiments, save months of expensive trial-and-error, and get more drugs to market, faster. Fully optimized bioprocessing promises to save pharma customers $100Ms in scale-up and biomanufacturing costs, helping to reverse the trend of skyrocketing drug development timelines and costs.
We are seeking a Frontend Software Engineer to take our novel simulation platform to the next level, working closely with our team of PhD-level bioprocess modelers. Our team of engineers is responsible for our own infrastructure, developer experience, on-call schedule, and release management, so you’ll get plenty of build our software experience from the ground up. You will own the direction of frontend development at Ark, while also playing a critical role in building full-stack features.
Our tech stack includes the following technologies:
- React
- Typescript
- Tailwind
- Docker
- Python 3.11
- FastAPI
- Postgres
- Dramatiq
About the company
Ark Biotech
- Top 1% of respondersArk Biotech is in the top 1% of companies in terms of response time to applications
- Responds within a dayBased on past data, Ark Biotech usually responds to incoming applications within a day
- B2B
- Early StageStartup in initial stages
- Top InvestorsThis company has received a significant amount of investment from top investors
- Recently fundedRaised funding in the past six months